mercredi 29 avril 2020

Gilead Claims ‘Positive Data’ to Come From N.I.H. Trial of Remdesivir

Neither the company nor the institutes discussed the data. Previous results for the potential coronavirus treatment have been inconclusive.

from NYT > Health https://ift.tt/2Yd2BfT
via health&fitness

Aucun commentaire:

Enregistrer un commentaire